Objectives To describe the acceptability, safety and effectiveness of neuromuscular electrical stimulation (NMES) in infants and young children with neurological impairment (NI) who have severe dysphagia.
Design A prospective pilot study using a before and after study design.
Setting The Hospital for Sick Children, Toronto, Canada.
Patients Ten infants and young children (0–24 months) with NI and severe dysphagia on videofluoroscopic swallow study (VFSS) who were referred to an occupational therapist (OT). Those with neurodegenerative conditions were excluded.
Intervention NMES treatments lasting 20–45 min twice weekly for the duration of 2–4 months. The NMES was administered during feeding therapy sessions by a trained OT.
Main outcome measures Improvement in swallowing function as measured by VFSS and the need for tube feeding, adverse events and parental acceptability.
Results Seven of 10 enrolled subjects (median age, 8.9 months) completed biweekly NMES treatments (median number of treatments per subject, 18). All of the seven (100%) subjects who completed treatment showed an improvement in swallow function on VFSS. Of the five patients who were not safe to orally feed on any consistency of liquid or puree at baseline, three established full oral feeding and two established partial oral feeding. At baseline, 5/7 children were completely fed by tube versus 0/7 at the end of treatment. No adverse events occurred other than mild skin irritation at the site of electrode placement. Five of seven caregivers felt that feeding was improved and were satisfied with the intervention.
Conclusions Our prospective pilot study of NMES in seven neurologically impaired infants and young children with severe dysphagia suggests that NMES is safe, acceptable to parents and has potential efficacy. Trials are needed to determine if any treatment benefit exists.
Trial registration ClinicalTrials.gov NCT01723358.
- infant feeding
- occupational therapy
This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
Statistics from Altmetric.com
Contributors All authors conceptualised and designed the study; contributed to data collection and analysis, interpretation of data; drafted and revised the article and gave final approval of the manuscript as submitted.
Funding This study was funded by a peer-reviewed grant from the Department of Paediatrics, The Hospital for Sick Children, Toronto. ALD was supported through the Norman Saunders Complex Care Initiative, Hospital for Sick Children. SM was supported through the Rehabilitation Department, Hospital for Sick Children.
Competing interests None declared.
Ethics approval The Hospital for Sick Children’s Research Ethics Board
Provenance and peer review Not commissioned; externally peer reviewed.
Patient consent for publication Not required.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.